Pionyr Immunotherapeutics is developing cancer immunotherapies that target the tumor microenvironment to enhance the body’s antitumor immunity.
- Year invested 2017
- Investment Stage Early
- Board Members
- Sectors
- Investment Status Current
- Associated Team
- Website pionyrtx.com
- Company Status Private